The colonic epithelium facilitates host-microorganism interactions to control mucosal immunity, coordinate nutrient recycling and form a mucus barrier. Breakdown of the epithelial barrier underpins inflammatory bowel disease (IBD). However, the specific contributions of each epithelial-cell subtype to this process are unknown. Here we profile single colonic epithelial cells from patients with IBD and unaffected controls. We identify previously unknown cellular subtypes, including gradients of progenitor cells, colonocytes and goblet cells within intestinal crypts. At the top of the crypts, we find a previously unknown absorptive cell, expressing the proton channel OTOP2 and the satiety peptide uroguanylin, that senses pH and is dysregulated in inflammation and cancer. In IBD, we observe a positional remodelling of goblet cells that coincides with downregulation of WFDC2-an antiprotease molecule that we find to be expressed by goblet cells and that inhibits bacterial growth. In vivo, WFDC2 preserves the integrity of tight junctions between epithelial cells and prevents invasion by commensal bacteria and mucosal inflammation. We delineate markers and transcriptional states, identify a colonic epithelial cell and uncover fundamental determinants of barrier breakdown in IBD.
1
. The epithelial barrier comprises specialized cells with diverse functions that emerge from stem cells at the crypt base. Most epithelial cells are absorptive colonocytes, which are interspersed with specialized epithelial lineages, including secretory goblet and enteroendocrine cells (EECs) 1 . Whether other epithelial-cell types exist in the human colon remains unclear.
IBD-which comprises ulcerative colitis and Crohn's disease-results from a breakdown of the symbiotic relationship between the intestinal commensal microflora and the mucosal immune system. Barrier defects characterize both forms of IBD, with goblet cells reportedly being depleted in ulcerative colitis and increased in Crohn's disease 2 . Key examples exist in which disruption of innate epithelial pathways drives colon inflammation (colitis), including autophagy defects 3 , endoplasmic-reticulum stress 4 , lipid antigen presentation 5 and inflammasome dysfunction 6 . Goblet cells are critical for the maintenance of the colonic barrier, through both the production of mucus and the transportation and presentation of luminal antigens to tolerogenic dendritic cells, particularly the CD103 + type 7 . Luminal secretion of mucins and antimicrobial proteins (AMPs) establishes a physical barrier to microbial contact. This forms inner and outer mucus layers, essential for maintaining homeostasis, with the inner mucus layer being reportedly sterile 8 . In the small intestine, secretion of AMPs by Paneth cells mediates this sterility 9 . However, the colon contains few or no Paneth cells, so the cell types that direct the release of colonic AMPs remain uncharacterized.
It is also unclear whether specific subsets of colonic epithelial cells show intrinsic molecular pathology in IBD. To study this, we used single-cell profiling to create a map of colonic epithelia in health and of clinically inflamed and noninflamed mucosa in ulcerative colitis. These maps identify an absorptive cell with a role in pH balance, as well as goblet-cell drivers of barrier breakdown.
Crypt gradients of absorptive and secretory cells
We isolated colonic biopsies from healthy volunteers or immunomodulatornaive patients with ulcerative colitis, sampled from clinically inflamed and noninflamed mucosa (Supplementary Table 1 ). Crypts were dissociated to single-cell suspensions and processed using droplet-sequencing technology, capturing 11,175 cells (Extended Data Fig. 1a, b and Methods) .
In healthy colons, we identified and visualized ten clusters of cells using t-distributed stochastic neighbourhood embedding (t-SNE) (Fig. 1a) ; these clusters included undifferentiated cells, absorptive colonocytes and distinct clusters of goblet cells and EECs (Fig. 1b) . EEC populations further divided into L-cells, enterochromaffin cells and precursor-like cells, identifying novel markers of colonic EECs (Extended Data Fig. 1c-e) . Isolating undifferentiated cells in silico, we further identified five subclusters: stem cells 10 , early transit-amplifying cells, transit-amplifying-like-cells defined by high expression of cellcycle-related genes, and secretory and absorptive lineage precursor cells (Extended Data Fig. 1f, g ). No Paneth cells were detected in the healthy colons (Extended Data Fig. 1b) .
Rather than discrete clusters of cells, we observed gene-expression gradients between single epithelial cells, consistent with an axis of Article reSeArcH differentiation that ascends through the crypt. We in silico-localized cells within the colonic crypt by defining a crypt-axis score (Methods), using 15 genes that are expressed in both absorptive and secretory cells (Fig. 1c) . Pseudotime analysis (Methods) confirmed a bifurcating trajectory, arising from stem cells, that separated secretory and absorptive lineages (Fig. 1d) , consistent with previously identified clusters and the crypt axis (Extended Data Fig. 1h ). Trajectory analysis identified known and putative new factors that could have roles in lineage commitment during differentiation (Extended Data Fig. 1i ). Therefore, single-cell RNA sequencing (scRNA-seq) highlights the extent of human colonic heterogeneity and supports the existence of a differentiation hierarchy in the crypt.
Discovery of a novel pH-sensing absorptive colonocyte
Clustering analysis identified a cell cluster (Fig. 1a) predicted to transport salt, ions and metals (Extended Data Fig. 1j ). The cells of this cluster expressed markers of mature colonocytes, with distinct expression of the calcium-sensitive chloride channel BEST4 (Fig. 2a, i, iii and Extended Data Fig. 2c, i) , the protease cathepsin E (Extended Data Fig. 2c , ii, iii) and the OTOP2 gene (Fig. 2a , ii, iii), so we designated these cells 'BEST4/OTOP2 cells' . BEST4 marks epithelia that are involved in electrolyte transportation 11 , and the OTOP gene family encodes proton-conducting ion channels in various epithelia 12 . The cells of this cluster also expressed the endogenous paracrine hormone and satiety peptide uroguanylin 13 (encoded by GUCA2B; Fig. 2a, iv, v, vi) , which is required for activation of guanylate cyclase 2C(GC-C) and epithelial cyclic GMP activity. Further, these cells expressed genes belonging to the metallothionein family, which impart defence against free radicals and contribute to metal transport and short-term storage 14 (Fig. 1b) . Trajectory analysis indicated that these cells originate from the absorptive lineage and express the transcription factors SPIB and HES4 (Extended Data Fig. 2c, iv, v) , with the latter normally confined to undifferentiated epithelial populations (Extended Data Fig. 2b ). We also identified these cells using semisupervised clustering in a human fetal colon dataset 15 (Extended Data Fig. 2d ), and found evidence for their loss in inflammation and colorectal cancer [16] [17] [18] [19] [20] [21] (Extended Data Figs. 2e, f, and see below).
We next isolated BEST4/OTOP2 cells (Extended Data Fig. 3a , b), and further characterized them using quantitative proteomics (Fig. 2b ) and deep scRNA-seq (Smart-Seq2) (Fig. 2c) . This enabled the identification of additional messenger RNA and protein markers (Extended Data Fig. 3c and Supplementary Information). Gene Ontology biological-process enrichment analysis of proteomic data highlighted processes that involve ethanol, small molecule and lipid catabolism; icosonoid and fatty acid metabolism; and neutrophil-mediated immunity (Extended Data Fig. 3d) .
Functionally, these cells conducted protons into the cell cytosol in response to lowering of the extracellular pH (pH o ); this proton conduction is seen here as an increase in emission of a membranepermeant pH indicator dye, pHrodo Red (Fig. 2d, i , ii), which corresponded to a substantial change in the intracellular pH (pH i ) (Fig. 2d, iii) . Intracellular acidification can be cytotoxic; however, our proteomics data indicate that BEST4/OTOP2 cells express high levels of the anti-apoptotic protein BAG1 (Fig. 2b) , which may enable survival following substantial pH changes. Expression of uroguanylin coincident with the ability to sense pH suggests that these cells have a role in setting colonic epithelial cGMP tone in response to luminal pH.
Gene responses in ulcerative colitis
We next sampled clinically inflamed and noninflamed tissue from early-diagnosis, immunotherapy-naive patients with ulcerative colitis (see Methods and Supplementary Table 1) . In inflamed tissue, in addition to the clusters that we identified in healthy colons, we detected two clusters that represent inflammation-associated goblet cells and intraepithelial immune cells (Fig. 3a) . Differential gene expression analysis between corresponding cell clusters revealed 1,147 genes (with a false discovery rate (FDR) of less than 1%) that are dysregulated in inflamed ulcerative colitis, with the greatest number of changes being seen in colonocytes (734) and crypt-top colonocytes (676), followed by goblet cells (140), stem cells (65) , BEST4/OTOP2 cells (28) and EECs (4) (Fig. 3b and Supplementary Information). We observed universal upregulation of several inflammatory pathways across most cell populations, including interferon-γ signalling, antigen presentation and cytokine production (Extended Data Fig. 4a ).
Single-cell profiling enabled us to dissect cell-type-specific responses to colitis. Colonocyte populations downregulated metabolic processes and simultaneously induced genes that are needed to produce reactive oxygen species and for microbial killing (for example, the SAA1, DMBT1 and PLA2G2A genes). The BEST4/OTOP2 cell population showed reduced expression of the metallothionein family and other ion-absorption genes ( Fig. 3b and Extended Data Fig. 4b ). Goblet cells upregulated stress-response genes that actively promoted cell survival in preference to apoptosis (Supplementary Information). LYZ, a Paneth-cell gene, was upregulated by lower-crypt goblet cells in inflammation ( Fig. 3b and Extended Data Fig. 4e ), and may mark the 'deep crypt secretory cells' of the colon 22 that are required to maintain the colonic stem cell niche and to protect stem cells from bacterial damage during colitis. Absorptive and secretory progenitor cells upregulated differentiation and cell-migration pathways, which suggests an active attempt to repair colitis-induced damage. By contrast, stem cells in inflammatory conditions showed downregulated expression of heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF; Extended Data Fig. 4d ). HB-EGF protects the intestine from injury by preserving Wnt/β-catenin signalling in intestinal stem cells after injury 23 . Failure to upregulate HB-EGF expression in ulcerative colitis may have an effect on Wnt signalling and negatively affect intestinal regeneration. Thus, overall, our data suggest that the outcome of this inflammatory event depends on how these individual cell subtypes balance the dual requirement to restore health and tissue integrity and simultaneously respond to aberrant tissue homeostasis.
IBD susceptibility genes in single colonocytes
As genetic analysis has implicated multiple pathways in IBD pathogenicity, we investigated whether specific genetic-risk genes might operate within distinct epithelial subtypes. Our analysis suggests that IBD susceptibility genes are expressed differently in unique cell populations (Extended Data Fig. 5a ).
We used the SNPsea 24 algorithm to test ulcerative-colitis-associated genomic loci 25, 26 for enrichment of expression specificity in our single-cell clusters, as well as additional scRNA-seq data from colonic mesenchymal cell populations 27 . We identified intra-epithelial T cells as the most IBD-associated cell type in healthy tissue. This association was driven by high and specific expression of genes such as IL7R and TNFRSF9 (refs. 25,28 ; Extended Data Fig. 5b ). 
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By contrast, using the same approach with inflamed ulcerative colitis samples, we observed a highly significant association (with an FDR of less than 1%) for some immune subsets and absorptive progenitor epithelial cell types (Fig. 3c) , with significant associations at alternative cut-offs (FDRs of less than 5% or of 10%) in other immune and epithelial subsets (Fig. 3c) . Inflamed crypt-top colonocytes differentially expressed the oxidative-stress-pathway genes NOS2 (Fig. 3d) and DDAH2 (ref. 29 ), and showed increased expression of SMAD3 (Extended Data Fig. 5b ) and JAK2, which are associated with both Crohn's disease and ulcerative colitis 25, 30 . IBD-associated ITLN1 (Fig. 3d) and IL1R2 (ref.
30
) were expressed by goblet cells, while undifferentiated epithelia expressed IBD-associated RNF186, the chemokines CXCL1, CXCL2 and CXCL3 (ref. 31 ), the integrin ITGB8 (ref.
25
) and the heat-shock-protein HSPA6 (ref.
28
) (Extended Data Fig. 5b ). These results suggest that the effects of diverse, small genetic defects may manifest in different cell types and contribute to the failure to re-establish epithelial barrier function in IBD.
Clinically uninvolved epithelia in ulcerative colitis
Comparing epithelial clusters between healthy, clinically involved and noninvolved ulcerative colitis revealed shifts in relative cell proportions (Extended Data Fig. 5d ). Differential expression analysis (Extended Data Figs. 5e, 6a, b) of uninvolved ulcerative colitis versus healthy mucosa identified 207 significantly dysregulated genes (FDR less than 1%). Notably, 59.4% (123 out of 207) of differentially expressed genes in uninvolved ulcerative colitis epithelia were also detected as differentially expressed in involved tissue (Extended Data  Fig. 6c) ; however, gene-expression changes limited to only noninflamed tissue in ulcerative colitis were also observed (Extended Data Figs. 4c, 6a, iii, iv) . Furthermore, we fit a generalized linear model to all of the data and found that model coefficients for inflamed and noninflamed samples were correlated, but with smaller effect sizes in noninflamed cells (Extended Data Fig. 6d ). Thus epithelia derived from proximal clinically noninflamed colon bear similar-albeit lower-amplitudetranscriptomic hallmarks to those derived from inflamed tissue. This subclinical pathology may arise as result of a dominance of regenerative over damage cues, or as a protective mechanism in anticipation of damage.
Goblet-cell diversity in health and ulcerative colitis
Although dysregulated goblet-cell function contributes to barrier breakdown in colitis, we do not yet know the pathways that underlie this breakdown. Single-cell profiles derived from goblet cells of healthy, inflamed or noninflamed ulcerative colitis tissue in isolation revealed partitioning of this cell group across five clusters (Fig. 4a ). We used a score denoting cellular position on the crypt-top to crypt-base axis and unsupervised pseudotime trajectory analysis to infer the localization and maturity of the goblet clusters (Extended Data Fig. 7b , i, ii). For instance, cluster 3 expressed secretory progenitor markers localized to the lower crypt, and cluster 5 localized towards the lumen-facing crypt top (Extended Data Fig. 7a, b, i) .
In ulcerative colitis, we observed both spatial and crypt-wide differences at the mRNA and protein levels. This suggested that, although common inflammatory responses exist, goblet cells in spatially distinct regions within the crypt also exhibit highly heterogeneous changes. For instance, the LCN2 and REG1A genes are induced throughout the crypt, whereas CD74 and LAMB3 expression was limited to the crypt bottom and top, respectively (Extended Data Fig. 7c ). We also observed transcriptional dysregulation, in which genes that are normally limited to the crypt bottom in healthy colons persist in crypt-top cells in inflammation (for example, SPINK4 and SPINK1; Extended Data Fig. 7c, iv, v, d, iii, iv) .
Consistent with these observations, we identified the emergence of a disease-associated cluster of goblet cells in cluster 4 (Extended Data Fig. 7e ), a counterpart with homology to the crypt-top cluster 5. Ulcerative-colitis-associated goblet cells expressed genes essential for the integrity and homeostasis of the epithelial barrier 32 (Extended Data  Fig. 7a , ii, g and Supplementary Information).
We validated these goblet-cell expression patterns by immunofluorescence. Figure 4b shows expression of the BCAS1 (cluster 5), CLCA1 (cluster 1), REGIV (cluster 1) and WFDC2 (cluster 2) proteins together with mucin 2 (MUC2) within goblet cells. CLCA1 and WFDC2 are expressed along a gradient that is higher at the bottom of the crypt (Fig. 4b , ii, iii) and is consistent with our in-silico maturity/crypt gradient predictions (Extended Data Fig. 7b ). By comparison, REGIV is observed mainly in the mid-to-upper portions of the crypt (Fig. 4b, iv) . Not all goblet cells expressed these proteins, a fact that is also consistent with segregation across subclusters. Double stains for WFDC2 and CLCA1 (Fig. 4b, v ) and WFDC2 and REGIV (Fig. 4b, vi) confirmed the heterogeneity of protein expression in goblet cells suggested by the single-cell profiles.
Goblet-cell WFDC2 loss in active ulcerative colitis
We found that the spatial architecture of goblet cells within the inflamed crypt was perturbed and associated with the dysregulation of numerous genes, including WFDC2. WFDC2 is normally highly expressed by crypt-base goblet cells (Extended Data Fig. 7b ) but is downregulated in inflammation (Extended Data Fig. 7f and Supplementary Information). We next investigated whether loss of WFDC2 expression is a hallmark 
Fig. 3 | Human colonic epithelium in active colitis. a, t-SNE plot of single-cell clusters in active ulcerative colitis (n = 3). b, Heat map showing key differentially expressed genes (FDR less than 1%; two-sided negative binomial likelihood ratio test; Benjamini-Hochberg multiple testing correction) between cell clusters in health and in active ulcerative colitis (n = 3). The colour indicates a fold change (expressed in log 2 ) (dark purple, downregulation; yellow, upregulation). The point size shows the confidence interval for the observation (−log 10 (FDR)). Point colour indicates fold change (FC (expressed in log 2 ). 1, BEST4/OTOP2 cells; 2, colonocytes; 3, enteroendocrine cells; 4, goblet cells; 5, stem cells; 6, absorptive progenitors; 7, secretory progenitors (SPs); 8, transit-amplifying cells (TAs); 9, crypt-top colonocytes. c, Significance level (−log 10 (FDR)) of tissue-specific-expression enrichment of ulcerative-colitis-associated GWAS loci in single-cell clusters in colonic epithelium (n = 3) and colonic mesenchyme 27 (n = 2) in healthy colons and active ulcerative colitis. Dashed lines indicate thresholds for (from left to right) 10%, 5% and 1% FDR cut-offs (SNPsea empirical distribution P value; BenjaminiHochberg multiple testing correction). S1-S4, stromal cells 1-4. d, t-SNE overlay of selected GWAS-identified, ulcerative-colitis-associated genes expressed specifically in crypt-top colonocytes (NOS2) and goblet cells (ITLN1) (n = 3).
Article reSeArcH of colitis in a larger cohort of patients, by analysing clinically noninflamed and inflamed sections from patients with mild or severe ulcerative colitis by immunohistochemical labelling of WFDC2. As a control for goblet-cell health, we also stained for MUC2. Expression of WFDC2 and MUC2 in patients with varying degrees of mucosal inflammation is shown in Fig. 4c . More-severely inflamed tissue sections showed a clear reduction in goblet-cell WFDC2 expression. Both visual and digital scoring ( Fig. 4d and Extended Data Fig. 7h ) confirmed substantial protein loss in these cells. Further, we showed a similar loss of Wfdc2 expression in mouse colonic tissue treated with dextran sodium sulfate (DSS), using RNA in situ hybridization (smISH) (Fig. 4e, i , ii) and quantitative reverse transcription (qRT)-PCR (Fig. 4f) .
Loss of WFDC2 expression in colitis cannot be explained by a direct effect of known genetic factors, as it does not segregate with IBD genome-wide association study (GWAS) loci. We hypothesized that the local milieu of inflammatory cytokines may dictate the expression levels of WFDC2 and other proteins, and the degree of residual barrier protection in colitis. Consistent with this hypothesis, we observed the expression of several interferon-induced genes in goblet cells (Extended Data Fig. 7i ) with a location-dependent bias, which suggests that at least some of the dysregulation in these cells could be attributed to secreted pro-inflammatory factors. We tested this hypothesis on a human colonic organoid model (Extended Data Fig. 8a , i, ii) that was stimulated with interferon-γ, and observed both distinct organoid morphology and downregulation of WFDC2 (Extended Data Fig. 8a, iii) . Given our data, one possible source of interferon-γ stimulation may be intra-epithelial lymphocytes (Extended Data Fig. 8a , iv).
Barrier integrity requires secreted WFDC2
WFDC2 has been proposed to regulate innate immunity through the inhibition of serine and cysteine proteases 33 . We found WFDC2 to be secreted both basally and apically, and to show increased expression in response to stimulation in HT29-MTX-E12 34 cells (Extended Data Fig. 8b , i, ii). It inhibited the proteolytic activity of the matrix metalloproteinases MMP12 and MMP13, the pathological induction of which in IBD can orchestrate tissue destruction 35 (Extended Data Fig. 8c , i, ii). Furthermore, knockdown of WFDC2 in vitro showed a disturbed cellular morphology with goblet-cell hyperplasia and dysregulated mucus attachment (Extended Data Fig. 8d ).
As the inner mucus layer covering the colonic epithelium is sterile 36 , we questioned whether WFDC2 secreted into the lumen may perpetuate this sterility via antibacterial activity. We found that recombinant WFDC2 produced a marked dose-dependent reduction in the viability of the Gram-positive bacteria Staphylococcus aureus and the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa. However, the viability of other Gram-positive (Enterococcus faecalis) and Gram-negative (Salmonella Typhimurium LT2) bacteria remained unaffected (Fig. 5a ). This selective bactericidal activity of WFDC2 at a concentration comparable to that of other intestinal AMPs 37,38 suggests a potential role in maintaining homeostasis by restricting epithelial-bacterial contact in vivo.
To test this, we explored the function of WFDC2 in vivo using heterozygous (Wfdc2 +/− ) mice, as homozygous deletion of Wfdc2 was embryonically lethal. smISH (Fig. 5b, i , ii) confirmed reduced levels of Wfdc2 mRNA in the colons of Wfdc2 +/− mice. Transmission electron microscopy (TEM) revealed abnormalities in colonic epithelial intercellular junctions (Fig. 5b, iv) , along with irregular distribution of microvilli, in Wfdc2 +/− mice ( Fig. 5b , vi) compared with wild-type littermates (Fig. 5b, iii, v) . Wfdc2 +/− mice presented with abnormal histology, with mild-to-modest epithelial hyperplasia (Methods), accompanied by lymphoid infiltration ( Fig. 5c and Extended Data Fig. 9a ).
We next explored whether the absence of Wfdc2 facilitates the breakdown of the inner-mucus sterility. Staining for MUC2 in colonic tissues with a preserved mucus layer 39 suggests that the inner mucus layer in heterozygous mice is considerably different (Extended Data Fig. 9b ). Gram staining identified colonies from both Gram-positive and Gramnegative bacteria in close proximity to epithelia of Wfdc2 +/− mice ( Fig. 5d, i , ii). Scanning electron microscopy (SEM) confirmed bacterial attachment and goblet-cell damage in Wfdc2 +/− mice ( Fig. 5d , iii, iv and Extended Data Fig. 9c ). Unlike in wild-type tissues (Fig. 5e, i ), TEM analysis of Wfdc2 +/− mice showed invading bacteria free in the epithelial cytoplasm within a matrix of vesicles, fibres and membrane fragments (Fig. 5e , ii, iii), along with cellular destruction, epithelial detachment and bacterial aggregates over the epithelial surface (Extended Data Fig. 9d , i-iv). Thus, our data show that WFDC2 is an important, goblet-cell-secreted, antibacterial defence factor that is required to prevent colonization, invasion and epithelial barrier breakdown. ; ii, CLCA1 (red) with MUC2 (green); iii, WFDC2 (red) with MUC2 (green); iv, REGIV (green) with MUC2 (red). v, vi, Heterogeneity in expression of these markers is also observed by double staining for WFDC2 (green) with CLCA1 (red; v) and for WFDC2 (red) with REGIV (green; vi). Scale bars, 20 μm (i), 50 μm (ii-iv, vi), 10 μm (v). c, Representative immunohistochemistry images of colon biopsies from inflamed and noninflamed regions of ulcerative colitis colon stained for WFDC2 (n = 31) and MUC2 (n = 24). The top panel shows WFDC2 and MUC2 expression in a patient with mild disease, and the bottom panel shows expression in severe inflammation. d, Quantification and distribution of change in WFDC2 and MUC2 expression (fold change (expressed in log 2 )) in inflamed versus noninflamed tissue from patients with varying disease severity (the 25th, 50th and 75th percentiles are shown). Each point is coloured and sized by severity score (automated quantification; see Methods). Triangles represent outliers (showing a decrease greater than 16-fold). Paired two-sided t-test: MUC2 (n = 24), P = 0.2485; WFDC2 (n = 31), P = 0.0001779. e, i, smISH of Wfdc2 in the colons of naive mice and of animals treated with DSS (a model of acute colitis) (n = 5 per group). ii, smISH quantification from colons of naive and DSS-treated mice (n = 5 per group; * * * P = 0.0008; unpaired twosided t-test; mean ± s.e.m. shown). f, Quantification of Wfdc2 expression relative to Gapdh expression by qRT-PCR from the colons of naive and DSS-treated mice (n = 4 per group; * P = 0.0086; unpaired two-sided t-test; mean ± s.e.m. shown).
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Discussion
We have presented the first, to our knowledge, large-scale scRNA-seq study of the human colonic epithelium in health and inflammation, which has revealed previously unknown cellular diversity and subtype-specific gene dysregulation in colitis.
We have characterized an absorptive cell type, the BEST4/OTOP2 cells, which are capable of pH sensing and may maintain luminal homeostasis through regulation of the GC-C signalling pathway. These cells selectively express uroguanylin, the endogenous paracrine hormone required for GC-C activation. GC-C receptor signalling occurs in a pH-dependent manner and modulates key physiological functions, including fluid and electrolyte homeostasis, maintenance of epithelial proliferation, barrier function, DNA integrity, epithelial-mesenchymal crosstalk and microbiota composition 40 . Dysregulation of this circuit underlies intestinal transformation. Our data show that these uroguanylin-producing colonic epithelial cells are depleted in IBD and colorectal cancer, which suggests a previously unknown mechanism by which this pathway is dysregulated in these diseases. This provides a further rationale for the use of US Food and Drug Administration (FDA)-approved uroguanylin mimetics, and has wide-ranging implications for future studies.
Furthermore, we have delineated the functional role of a colonic goblet-cell-secreted antibacterial protein, WFDC2, in mucosal barrier homeostasis. We find this protein to be localized towards the bottom half of the crypt in healthy colons and to be dysregulated in ulcerative colitis. Evidence exists for how regional differences in goblet-cell phenotypes may affect key aspects of crypt physiology, such as barrier mucus. Colonic mucus is composed of inner and outer layers, the outer layer being unattached and creating a habitat for microbiota 36 . The antiprotease activity of WFDC2 inhibits the activities of serine and cysteine proteases, preventing the premature conversion of the inner mucus layer to the outer layer in health. Indeed, knockdown of WFDC2 expression results in abnormalities in mucus-layer formation (Extended Data Figs. 8d, 9b) . These mucus defects may allow bacteria to penetrate the mucus layer and to contact epithelial cells ( . Recent mouse studies support the existence of functional subpopulations of goblet cells, with differing rates of mucus production and secretion along the crypt axis 42 . Our work provides a basis for the spatial interrogation of goblet-cell phenotypes, key aspects of crypt physiology and how this specialization breaks down in barrier diseases such as ulcerative colitis.
Online content
Any methods, additional references, Nature Research reporting summaries, source data, statements of data availability and associated accession codes are available at https://doi.org/10.1038/s41586-019-0992-y. +/− mice compared with wild-type animals (iii, v). Scale bars, 100 μm (i, ii), 1 μm (iii), 2 μm (iv-vi). c, i-vi, Histopathological evaluation of changes in epithelialcell morphology and mucosal architecture. Wfdc2 +/− mice (ii, iv, vi) show irregular crypts with variable diameters along the depth of single crypts (ii) and focal mucosal infiltration of leukocytes (iv, vi) compared with wild-type littermates (i, iii, v). Magnification, i, ×20; ii-vi, ×40. H&E, haemotoxylin and eosin. d, i, ii, Gram staining identifies regions that are free from luminal contents above the epithelial layer in wild-type mice (arrow in i), but also indicate colonization by both Gram-positive and Gram-negative bacteria (arrows) in Wfdc2 +/− mice (ii). iii, iv, SEM of the colonic surface shows bacteria invading goblet cells in Wfdc2 +/− mice (iv) compared with wild-type mice (iii). Scale bars, 10 μm (i, ii), 2 μm (iii, iv). e, TEM analysis shows bacteria invading the Wfdc2 +/− colonic tissue, mostly through goblet cells (ii, iii). Bacteria were not confined to a membrane-bound compartment but were located free in the cytoplasm. No invasion of epithelial surfaces is observed in the wild-type littermates; the epithelium is intact with preserved colonocytes and goblet cells (i). Scale bars, 5 μm (i), 10 μm (ii, left, iii, left), 2 μm (ii, right, iii, right). In b-e, n = 4 per group. 345-349 (2012 
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7. McDole, J. R. et al. Goblet cells deliver luminal antigen to CD103 + dendritic cells in the small intestine. Nature 483,
MEthodS
No statistical methods were used to predetermine sample size. The experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. Isolation of epithelial cells from patient biopsies. Following informed consent, biopsies were collected from volunteers attending endoscopy for routine colonoscopic screening (healthy individuals), or as part of ongoing clinical care (patients with IBD; see Supplementary Table 1 for demographics). For ulcerative colitis, we used tissue derived from immunotherapy-naive patients with a proven histological diagnosis. Tissue was sampled from clinically inflamed distal colons and proximal clinically noninvolved regions. NHS National Research Ethics Service (NRES) research ethics committee (REC) references for the study include GI 16/YH/0247 and IBD 09/H1204/30. Biopsies were incubated in chelation medium (HPGA with 1 mM EDTA) at 37 °C for 80 min with agitation. The supernatant, which was removed and replaced every 20 minutes and contained epithelial crypts, was digested into a single-cell suspension by dissociation with TrypLE Express containing 50 μg ml −1 DNase for 1 h at 37 °C. The epithelial single-cell suspension was washed and passed through 70-μm and 40-μm filters. Cell counts and viability were confirmed with a Countess II automated cell counter (Thermo Fisher) with confirmation by manual haemocytometer before further processing.
In all single-cell and exploratory experiments, samples were processed immediately. For some validation experiments (RT-PCR, flow-cytometry panel validation and flow sorting), in which large numbers of samples (more than four) were processed simultaneously, samples were stored by freezing in 1 ml of Cryostor DS10 (Sigma Aldrich). Samples were then thawed and epithelial cells isolated to allow batch processing. Viability and epithelial-cell purity were similar to those of freshly isolated samples (data not shown). Flow cytometry. Before progressing to scRNA-seq, the purity of epithelial populations was confirmed by fluorescence-activated cell sorting (FACS) analysis using anti-CD90 staining (fluorescein isothiocyanate (FITC); Biolegend), anti-CD326 antibody (epithelial cell adhesion molecule (EPCAM); PeVio, Milteyni), anti-CD45 staining (allophycocyanin (APC); Milteyni) and anti-DNA staining (4′,6-diamidino-2-phenylindole (DAPI); BD Biosciences) as per the manufacturers' instructions. Samples were processed on an Attune NxT flow cytometer (Thermo Fisher) with compensation performed using compensation beads (BD Biosciences) on each run. Once satisfactory viability and EPCAM purity had been demonstrated, samples were directly processed for scRNA-seq.
For validation of the BEST4/OTOP2 cell subpopulation, a similar epithelial staining protocol was used, with addition of a primary anti-BEST4 antibody (Atlas Antibodies), followed by secondary staining for 30 min with Alexa Fluor 488 anti-rabbit secondary antibody (Invitrogen). The staining protocol was validated on the Attune NxT flow cytometer (Thermo Fisher) and then flow sorting was performed on a Sony SH800 cell sorter (Sony) with BEST4 + gates set on fluorescence minus one and secondary control, each of more than 20,000 cells. Droplet-based single-cell RNA sequencing. Cells were loaded onto the 10X Chromium Single Cell Platform (10X Genomics) at a concentration of 1,000 cells per μl (Single Cell 3′ library and Gel Bead Kit v.2) as described in the manufacturer's protocol (10x User Guide, Revision B). On average, approximately 8,000 cells were loaded across three runs, each with three conditions: healthy, ulcerative colitis inflamed and ulcerative colitis noninflamed. Cells were suspended in phosphate-buffered saline (PBS) with 0.04% bovine serum albumin (BSA). Generation of gel beads in emulsion (GEMs), barcoding, GEM-RT clean-up, complementary DNA amplification and library construction were all performed as per the manufacturer's protocol. Individual sample quality was checked using a Bioanalyzer Tapestation (Agilent). Qubit was used for library quantification before pooling. The final library pool was sequenced on the Illumina NovaSeq6000 instrument using 150-base-pair paired-end reads. Average cell recovery was 1,400 cells per sample, with a total of 11,175 cells captured at a mean depth of 163,822 reads per cell and 1,736 mean genes per cell. Plate-based scRNAseq, real-time PCR and RNA amplification. Single cells were sorted as previously described and plate-based scRNA-seq was performed as per the Smart-seq2 protocol 43 with minor adaptations. Reverse transcription was carried out with 0.75 units per reaction of SMARTScribe (Clonotech, Takara) and PCR pre-amplification with 5′-biotinylated IS PCR primers (Biomers) for 25 cycles. Post-PCR cleaning was performed with Ampure XP Beads (Beckman Coulter) at a ratio of 0.8/1 (beads/cDNA). cDNA was resuspended in elution buffer (Qiagen) and quality assessed with a high-sensitivity DNA chip (Agilent).
Barcoded Illumina sequencing libraries (Nextera XT, Library preparation kit, Illumina) were generated using the automated platform (Biomek FXp), and libraries were pooled and sequenced using the Illumina NextSeq sequencer.
For bulk RNA amplification in small cell numbers (12,500-25,000), RNA was isolated using the RNAeasy MicroKit (Qiagen) according to the manufacturer's instructions. We then added 1 μl of extracted RNA to a 96-well plate containing lysis buffer and processed it with the same SMART-seq2 protocol with 20 cycles of pre-amplification.
For microfluidic quantitative PCR of small cell numbers, 100 BEST4 + and 100 BEST4 − cells were isolated from three biological replicates. RNA was amplified using a specific targeted amplification strategy targeting the specified gene primers (Taqman, ThermoFisher) in the reverse-transcription mix as per manufacturers' protocols (Biomark, Fluidigm). The primers used are described in Supplementary  Table 3 . The expression of 12 genes was quantified using an integrated microfluidic chip (Flex 6 IFC) as per manufacturers' instructions (Biomark, Fluidigm). A sample with no reverse transcriptase was included as a control.
For quantitative RT-PCR experiments with larger cell numbers (more than 25,000 cells), total RNA was isolated using the RNeasy microkit (Qiagen) according to manufacturer's instructions. cDNA was then synthesized using the high-capacity RNA-to-cDNA kit (ThermoFisher 4387406), with RT-PCR then performed using applicable Taqman gene expression assays on the QuantStudio 7-Flex system (ThermoFisher). Details of individual gene-expression assays are included in Supplementary Table 3 . Proteomic analysis of BEST4/OTOP2 cell population. To characterize the BEST4/OTOP2 cell population by proteomics, we isolated BEST4 + EPCAM + and BEST4 − EPCAM + populations using FACS as previously described. We sorted 6,250 cells in both conditions into 25 μl of lysis buffer, which consists of radioimmunoprecipitation assay (RIPA) buffer (Sigma) with 4% NP-40 (IPEGAL, Sigma). After thawing, 1 μl of benzonase (E1014, Sigma) was added and samples were kept on ice for 30 min. Protein lysates were digested using a modified SP3 protocol 44 . In brief, proteins were reduced with 5 mM dithiothreitol for 30 min and then alkylated with 20 mM iodoacetamide for 30 min at room temperature. We then mixed 2 μl of carboxyl-modified paramagnetic beads (prepared as in ref. 45 ) with the samples. Acetonitrile was added to the samples to a final concentration of 70% (v/v). Protein binding to the beads was carried out for 18 min with orbital shaking at 1,000 r.p.m. Beads were then immobilized on a magnet for 2 min and the supernatant discarded. Beads were washed twice with 70% (v/v) ethanol and once with 100% acetonitrile, all on the magnet. Beads were resuspended in 50 mM ammonium bicarbonate containing 25 ng trypsin and digested overnight at 37 °C. After digestion, the beads were resuspended by brief bath sonication. Acetonitrile was added to 95% (v/v), and samples were shaken at 1,000 r.p.m. for 18 min to bind peptides; beads were then immobilized on the magnet for 2 min and the supernatant discarded. Beads were resuspended in 2% dimethylsulfoxide (DMSO) and then immobilized on the magnet for 5 min; the supernatant was transferred to liquid chromatography-mass spectrometry (LC-MS) vials, which were stored at −20 °C until analysis.
Peptides were analysed by nanoscale ultraperformance liquid chromatography coupled to tandem mass spectrometry using a Dionex Ultimate 3000 coupled on-line to an Orbitrap Fusion Lumos mass spectrometer (Thermo Scientific). A 75 μm × 500-mm C18 EASY-Spray column (Thermo Scientific) with 2-μm particles was used at a flow rate of 250 nl min −1 . Peptides were separated using a 60-min linear gradient from 2% buffer B to 35% buffer B (A: 5% DMSO, 0.1% formic acid in water; B: 5% DMSO, 0.1% formic acid in acetonitrile). Precursor scans in the first stage of mass spectrometry (MS1) were performed in the Orbitrap at a resolution of 120,000, a mass-to-charge ratio (m/z) of 200 and a rate of 1 Hz. Precursors were selected for tandem mass spectrometry analysis using an isolation window of 1.6 m/z and were fragmented using higher-energy collision dissociation (HCD) at a normalized collision energy of 28. MS2 fragment spectra were acquired in the ion trap using the Rapid scan rate. pH imaging. pH imaging was carried out as previously described 12 . In brief, sorted BEST4 + EPCAM + and BEST4 − EPCAM + cells were plated onto poly-l-lysinecoated coverslips at 37 °C. After at least 1 hour, cells were loaded with the intracellular pH indicator pHrodo Red AM, using PowerLoad concentrate according to the manufacturer's instructions (Molecular Probes). pH imaging optics and image acquisition were measured using an Olympus DeltaVision II Microscope System. pHrodo red fluorescence intensity for each cell was measured in response to pH 5.0 solution buffered with 2-(N-morpholino)ethanesulfonic acid (MES; 150 mM NaCl, 10 mM MES, 2 mM CaCl 2 ). The pHrodo Red fluorescence intensity of each cell was normalized to its baseline fluorescence in pH 7.4 solution (F 0 ) before the first acid application to determine F/F 0 . Cells were then permeabilized with valinomycin and nigericin, and fluorescence measured in high K + -containing extracellular solutions at pHs 4.5, 5.5, 6.5 and 7.5 . A standard curve was generated and the pH i for each cell was calculated using linear extrapolation. Immunohistochemistry, immunofluorescence and smISH. For immunohistochemistry, paraffin-embedded tissue sections were deparaffinized through an ethanol gradient, and heat-induced epitope retrieval was performed by boiling at 96 °C for 25 min in either pH 6 citrate or pH 9 Tris/EDTA buffers. Peroxidase was blocked before incubation with an appropriate species-specific serum for primary-antibody incubation of 90 min at room temperature. For full details on the antibodies and concentrations used, see Supplementary Table 2 .
Substrate development was performed for each primary antibody using ImmPACT diaminobenzidine (DAB), VectorBlue or NovaRed as appropriate for brown, blue or red development as required (all from Vector Laboratories). In cases of double staining, samples underwent sequential heat-induced epitope retrieval if labelled with same-species antibodies. Haematoxylin and eosin staining was carried out using a kit from Vector Laboratories.
For immunofluorescence, the protocol was followed exactly as described above except that the primary antibodies were incubated overnight at 4 °C. Slides were then washed in PBS and incubated with the appropriate secondary antibodies labelled with Alexa Fluor (Molecular Probes) for 1 h at room temperature in the dark. Slides were washed again and incubated with DAPI for 5 min before washing and mounting using Vectashield (Vector Laboratories).
For smISH, all probes and RNAscope 2.5 HD assay-brown (catalogue number 310035) were purchased from Advanced Cell Diagnostics (ACD) and used according to the manufacturer's instructions. Details of probes are in Supplementary Table 2 . Paraffin sections were pretreated with Pretreat 1, 2, and 3 (ACD). Prewarmed (40 °C) probes were added to the slides and incubated in a HybEZ oven (catalogue number 321461; ACD) for 2 h at 40 °C. After six-step signal amplification, tissues were detected using DAB (all part of the RNAscope 2.5 HD assay-brown kit) and counterstained with Mayer's haematoxylin. Slides were mounted with Pertex mounting medium and photographed.
For double staining in smISH and immunohistochemistry (to detect OTOP2 and BEST4), samples were processed in a manner identical to smISH, with subsequent overnight staining with anti-BEST4 antibodies and development with VectorBlue.
Transwell cultures at 21 days old were fixed using 10% neutral buffered formalin, then membranes were cut out and paraffin-embedded. Haematoxylin and eosin and Alcian blue stains were carried out according to the manufacturers' protocols (Vector Laboratories and Sigma-Aldrich, respectively). For experiments involving staining the mucus layers in mice, the colon was dissected along with faecal content and fixed in chloroform-based Carnoy's fixative 46 . The tissue was fixed overnight, following by washing in methanol and paraffin embedding as usual. Quantification of patient biopsies using Visiopharm. Slides stained for WFDC2 as described above were scanned using a Leica ScanScope machine (Leica Biosystems) and quantified using Visiopharm (Visiopharm) with a programmed protocol calculated as follows: percentage of positive goblet-cell area = fraction of goblet-cell area × 100, in which the fraction of goblet-cell area was calculated as the goblet-cell area (area inside region of interest (ROI) 1, set on a defined image) as a fraction of the area of interest (total ROI2 in a defined image). The protocol was set to repeat the calculation randomly for 50% of the whole biopsy and give an average for each sample. The result was equated to the percentage of positive/brown stain in goblet cells for each biopsy. For the data presented in Fig. 4d , additional unmatched patient data for WFDC2 were included. Antibacterial activity. Mid-logarithmic-phase cultures of ATCC12973 S. aureus, ATCC13379 E. faecalis, ATCC27853 P. aeruginosa, S. Typhimurium LT2 and E. coli were incubated with diluted PBS containing Lucia Bertani (LB), tryptic soy broth (TSB) or brain and heart broth (all Sigma-Aldrich) to a concentration of 2 × 10 4 colony-forming units per ml. A final volume of 100 μl was used to measure antibacterial activity of recombinant WFDC2 (Abcam) by addition at a concentration of between 0.45-4.50 μM. Following a 4-h incubation at 37 °C, the frequency of bacteria was determined by serial dilution onto LB agar or Columbia blood agar (CBA) plates (Sigma-Aldrich). All plates were incubated overnight and before counting bacterial colonies. Survival was calculated as the percentage of bacteria present at 4 h compared with baseline. All experiments were performed three times. Antiprotease activity. MMP-inhibitor activity was performed according to the manufacturer's protocol (Enzo Life Sciences: MMP12, catalogue number BML-AK403-0001; MMP13, BML-AK413-0001). In brief, all kit components were diluted according to the recommended concentration. We added 20 μl of each MMP (with varying concentrations; refer to the manufacturer's manual for lot-dependent variations) to control, inhibitor N-isobutyl-N-(4-methoxyphenylsulfonyl)glycl hydroxamic acid (NNGH) and WFDC2 (25 μg ml
−1
). The reaction plate was incubated for 30 min at 37 °C to allow inhibitor and enzyme interaction. Next, 10 μl of substrate BML-P277-9090 was added to each reaction and the fluorescence was measured at an excitation/emission of 545 nm/576 nm for 10 min at 37 °C. Animals. For Wfdc2 experiments, mice were housed under standard conditions in the MRC Harwell animal facility according to institutional guidelines. Mice heterozygous for the targeted Wfdc2 allele (Wfdc2
em1(IMPC)H
) were generated by injecting targeted embryonic stem cells (obtained from the European Mouse Mutant Archive) into blastocysts (MRC Harwell Transgenic Facility) [47] [48] [49] . For DSS colitis experiments, we used 10-12-week-old C57BL/6 male mice (free from Helicobacter pylori and murine norovirus; Envigo Laboratories). All procedures were certified according to the UK Home Office Animals (Scientific Procedures) Act 1986 (project license P9B86E6FD). Ten mice were randomized into two treatment groups of five mice each. One group received no treatment and the other received 1.75% DSS (molecular weight 36-50 kDa; MP Biomedicals, lot M9147) in their drinking water from study day 0 until mice were euthanized on the morning of study day 7, and the tissue processed for routine immunohistochemistry as described above. For another independent study, we used a group of eight mice with four mice per group, treated with DSS as described above. RNA isolation from tissue was performed using a Qiagen mini kit (Qiagen), as described earlier.
Wfdc2 +/− mice were assigned a subjective colitis severity score based on a modification of the criteria in ref. 50 . Scores for morphology, ulceration and infiltration were ranked on a scale from 0 (normal or absent) to 4 (severe), which were summed to give an overall score. SEM and TEM. Mice underwent perfusion fixation with 2.5% glutaraldehyde plus 4% paraformaldehyde in 0.1 M sodium cacodylate and the colon was excised. Tissue was cut into pieces of 2-3 mm 3 and then stored at 4 °C in 0.25% glutaraldehyde in 0.1 M sodium cacodylate buffer, until processing for TEM. Samples were washed with 0.1 M sodium cacodylate buffer followed by 50 nM glycine in the same buffer to quench free aldehydes, followed by another wash with 0.1 M sodium cacodylate buffer. Samples were incubated in 1% osmium tetroxide plus 1.5% potassium ferrocyanide in 0.1 M sodium cacodylate buffer for 2 h at 4 °C with vigorous agitation, and then washed with water, before overnight incubation at 4 °C in 0.5% uranyl acetate. Samples were washed with water and dehydrated through a graded series of ice-cold ethanol for 15 min each followed by a final incubation in 100% ice-cold ethanol for 90 min. Samples were then infiltrated with 25% agar low viscosity epoxy resin (Agar Scientific) in ethanol for 3 h and then 50% resin overnight, followed by 75% and 100% resin each for 3 h and then 100% resin overnight. The samples were embedded in flat-dish moulds and polymerized at 60 °C for 48 h. Ultrathin (90-nm) sections were cut with a Diatome diamond knife using a Leica UC7 ultramicrotome and post-stained for 5 min with lead citrate. Sections were viewed on a FEI Tecnai 12 TEM operated at 120 kV equipped with a Gatan OneView digital camera.
For SEM, colons were fixed and processed as above, and dehydrated in a graded ethanol series as above. They were then incubated in absolute ethanol at room temperature, dried by critical point drying (Tousimis Autosamdri-815b), and placed on an SEM stub using conductive silver dag and sputter-coated with gold in a Quorum Q150R ES coating unit. Specimens were imaged using a Zeiss Sigma 300 field emission gun SEM at an acceleration voltage of 2 kV. Cell culture. A goblet-cell-producing cell line, HT29-MTX-E12 (ref. 34 ), was obtained from ATCC and maintained in Dulbecco's modified Eagle's medium (DMEM) glutamax medium (Life Technologies) containing 10% fetal bovine serum (v/v) and 1% (v/v) antibiotics. Cultures were incubated at 37 °C in a humidified 5% (v/v) CO 2 atmosphere and used between passages 10 to 20. For secretion assays, cells were seeded in 24-well culture plates at a concentration of 4.0 × 10 4 cells per well. The culture medium was changed every two days, and medium without antibiotics and serum was used for the last medium change. Experiments were performed 21 days post-seeding 51 . Cells were stimulated with or without 100 ng ml −1 of phorbol 12-myristate 13-acetate (PMA) for 6 h before apical and basal medium collection. WFDC2 was quantified using a human WFDC2 Quantikine ELISA kit according to the manufacturer's instructions (R&D Systems). Knockdown of WFDC2 with small hairpin RNA. A small hairpin RNA (shRNA) oligo targeting WFDC2 was purchased from Sigma (catalogue number SHCLNG-NM_006103) (Supplementary Table 4 ). HEK-293 T cells were transfected with WFDC2 shRNA along with packaging vectors, using lipofectamine as per the manufacturer's instructions (Thermo Fisher Scientific). Viral supernatant was collected 72 h after transfection, and concentrated by ultra-centrifugation. Cells were transduced with concentrated lentiviral particles expressing WFDC2 shRNA in the presence of polybrene as described 52 . Knockdown efficiency was assessed by immunoblotting for WFDC2 and secretion of WFDC2 in culture supernatant. Organoid cultures. Organoid cultures were established as previously described 53 . In brief, cultures were established from four pairs of colonic biopsies, incubated with 0.4 mg ml −1 dispase (Gibco) to establish a single-cell suspension. This was then mixed with 50 μl Matrigel (Corning) and plated on prewarmed 24-well culture dishes. Embedded cells were overlaid with WREN medium (WNT3A conditioned medium, containing lipid-modified WNT3A; ATCC catalogue number CRL:2647TM) and ADF (advanced DMEM-F12 medium; Gibco) 50/50, glutamax (Life Technologies), 10 mM HEPES, N-2 supplement (×1) (Life Technologies), B-27 supplement (×1) (Life Technologies), 10 mM nicotinamide (Sigma Aldrich), 1 mM N-acetyl-l-cysteine (Sigma Aldrich), 1 μg ml −1 R-spondin 1 (RSPO1; Peprotech), 50 ng ml −1 human epidermal growth factor (EGF; Peprotech), 100 ng ml −1 human Noggin (Peprotech), 1 μg ml −1 gastrin (Sigma Aldrich), 0.05 μM prostaglandin E2 (Sigma Aldrich), 0.1 μM A83-01 (an inhibitor of activin receptor-like kinases), 10 μM p38 inhibitor SB202190, and 10 μM Y27632 Article reSeArcH (a Rho-associated kinase inhibitor) (all from R&D Systems). Medium was replaced with fresh WREN medium every other day.
For organoid-stimulation experiments, once organoid cultures were established, 100 ng ml −1 interferon-γ was added to medium for four days in experimental conditions. For gene-expression quantification, we isolated RNA from organoids and performed RT-PCR as described above. Computational analysis. Raw 10× read processing and quality control. Raw sequence reads were quality-checked using FastQC software. The Cell Ranger version 2.1.1 software suite from 10× Genomics (https://support.10xgenomics. com/single-cell-gene-expression/software/downloads/latest) was used to process, align and summarize unique molecular identifier (UMI) counts against the human hg38 assembly reference genome analysis set, obtained from the University of California Santa Cruz (UCSC) ftp site 54 . Corresponding Ensembl gene annotation was obtained using the UCSC Table  Browser Tool   55 . Raw, unfiltered count matrices were imported into R for further processing.
Raw UMI count matrices were filtered to remove: barcodes with very low (empty wells) and very high (probably doublets) total UMI counts; matrices for which a high percentage of UMIs originated from mitochondrial features (more than 20%); and matrices for which fewer than 200 genes were expressed. Distributions of UMIs per cell per sample were visualized using the ggplot2 R package (Extended Data Fig. 10a) .
The Seurat R package (version 2.3.2) was used to normalize expression values for total UMI counts per cell 56 . Assessment of mRNA content per cell. Cell Ranger software version 2.1.1 was used to downsample data to the level of the lowest coverage sample on the basis of the aligned number of reads per cell. Downsampled UMI count matrices were used to obtain the gene cellular detection rate, in which a gene was considered detected if at least one UMI was assigned to it. The numbers of genes detected per cell for ulcerative colitis inflamed and noninflamed tissue and for healthy samples were visualized as density distributions (Extended Data Fig. 10b ). Distributions of gene-detection rates were also visualized on a per-cell-type basis (Extended Data Fig. 10c) . Clustering. Initially an integrated clustering analysis of all samples (Extended Data Fig. 10d ) was performed and was then used to guide complementary cluster identification between conditions. Clustering was performed as follows. Cell-cyclestage annotation was performed using the 'cyclone' function from the R package scran (version 1.6.9) 57 . The resulting G 2 M and G 1 phase cell-cycle scores together with total UMI counts per cell, the percentage of mitochondrial features and experimental batches were considered to be a source of unwanted variation and were regressed out using the Seurat package. Variable genes were found either by identifying outliers from fitting the mean-variance relationship in the data, or by fitting the relationship between mean expression and drop-out rate using the R package M3Drop (version 1.6.0). Dimensionality reduction was performed using principal-component analysis (R package irlba, version 2.3.2) . Scree plots and JackStraw permutation tests were used to determine significant principal components (with a P value cut-off of less than 0.01) in the data, and cells were clustered in the reduced dimension space using the Seurat package (resolution = 0.7). Cell clusters were visualized using t-SNE plots, with all significant principal components (as previously determined by Jack-Straw permutation tests) as input and a perplexity value of 30. We found 20 principal components to be significant and used them to cluster the whole dataset; 8 were used for clustering analysis of undifferentiated cells, 10 for goblet subcluster analysis and 6 for EEC analysis. Batch-effect assessment. To ensure that clustering was not driven by batch effects, we visualized batch distributions for the dataset using t-SNE plots (Extended Data  Fig. 10e ). We also quantified this effect by computing entropy of batch mixing, as described in ref. 58 , for t-SNE cell embeddings of sample batches. As a negative control (no batch effect), we assigned each cell a random batch label and computed the expected entropy. Similarly, as a positive control (in which clustering is driven entirely by batch effects), we used cluster identities as batch labels for entropy calculations. Each set of entropies was computed from the neighbourhoods of 100 randomly picked cell locations, bootstrapped 100 times and the distributions visualized as box plots (Extended Data Fig. 10f ). Crypt-axis score. The expression of the following genes was used to define a crypt-axis score: SEPP1, CEACAM7, PLAC8, CEACAM1, TSPAN1, CEACAM5, CEACAM6, IFI27, DHRS9, KRT20, RHOC, CD177, PKIB, HPGD and LYPD8 . For each gene, we normalized expression across all cells to a range between 0 and 1, to ensure that the contribution of individual genes to the score was not weighted by baseline expression. The final crypt-axis score for each cell was then defined as the sum of all normalized expression values. Semisupervised clustering of public scRNA-seq data. To test whether BEST4/OTOP2 cells are present in other single-cell datasets, we downloaded data from the Gene Expression Omnibus (GEO; accessions GSE103239 and GSE81861), processing the data as described above, except that clustering was performed using the a priori identified highly variable genes from our 10× data analysis. Cluster markers were detected as before and compared to the BEST4/OTOP2 cell markers in the 10× data. Analysis of The Cancer Genome Atlas data. High-throughput-sequencing raw count matrixes were downloaded from The Cancer Genome Atlas (TCGA) (https:// cancergenome.nih.gov) for all available patients with colorectal cancer and matched normal samples. Data were normalized using the DESeq2 R package and variance stabilized using the 'rlog' function 59 . Sample clustering and expression of the core BEST4/OTOP2 cell gene signature in this dataset were visualized using the R package pheatmap. Cluster marker and differentially expressed gene identification. Cluster gene markers were detected with the Seurat package, using the area-under-curve classifier and/ or negative binomial likelihood ratio tests. Differentially expressed genes between groups in each cluster were detected using the negative binomial likelihood ratio test. Patient/sample batches, total UMI counts, percentage mitochondrial gene expression and cell-cycle scores were used as model covariates. The BenjaminiHochberg multiple testing correction was applied and genes with an FDR of less than 1% were considered to be differentially expressed.
The R package MAST 60 was used to estimate generalized linear model coefficients for inflamed and noninflamed samples, using cells from healthy patients as a reference level. We built individual models for all major cell clusters using the 'zmb' function, in which-in addition to ulcerative colitis status (inflamed, noninflamed or healthy)-we modelled gene-detection rate, cell-cycle and donor effects. Correlation between coefficients was visualized as a scatter plot between individual genes. Differentially expressed gene identification from publicly available microarray data. Data were downloaded from the GEO (accession number GSE59071) for inflamed colon ulcerative colitis samples and healthy controls. The R package limma was used for data normalization and differential expression analysis 61 . The BenjaminiHochberg multiple testing correction was applied to estimate the FDR. Ontology enrichment analysis. Biological-process Gene Ontology enrichment of cluster markers and differentially expressed genes/proteins was performed using the R package clusterProfiler version 62 with a Benjamini-Hochberg multiple testing adjustment and an FDR cut-off of 0.05, using all expressed/detected genes as a background control. The results were visualized as dot plots or emap plots using the clusterProfiler and ggplot2 R packages. Smart-seq2 scRNA-seq data processing and analysis. Raw sequencing data were demultiplexed into one fastq file per plate well using bcl2fastq software, version 2.20.0.422. Reads were quality checked using FastQC software. Illumina Nextera sequencing adapters, Smart-seq2 oligonucleotide sequences, poly-d(T) and poor-quality (fewer than 20-base-pair) sequences were trimmed using Cutadapt software. Reads were aligned to the human hg38 reference genome build (UCSC) using the STAR aligner 63 . Raw read-count matrices were obtained using the featureCounts tool. Data-quality metrics for each well were aggregated using multiQC tool.
The R package scater was used to process raw count data. Poor-quality wells were filtered on the basis of the following criteria: less than 60% of reads uniquely mapped, less than 500 genes detected, more than 20% of reads mapping to mitochondrial features. Library normalization size factors were computed using the R package SCNorm 64 . A small number of contaminating immune cells was identified by expression of CD45/PTPRC and filtered out from the analysis. BEST4/ OTOP2 cell marker genes were identified using the R package Seurat as described. Proteomics data analysis. Label-free quantification of proteins was performed using Progenesis QI for Proteomics (version 4.1, Waters) and proteins were identified using MASCOT (Matrix Science) by searching against the Uniprot reference human proteome (95,128 sequences, database accessed on 18 July 2018). Precursor mass tolerance was set to 10 parts per million; fragment mass tolerance was 0.5 Da; and a maximum of two missed cleavages were allowed. Carbamidomethylation of cysteine was set as a fixed modification; the variable modifications allowed were deamidation of asparagine/glutamine and oxidation of methionine. Peptide FDR was adjusted to 1% and low-scoring peptides (less than 20) were excluded. The R package limma was used for normalization of protein expression and differential expression analysis 61 . The Benjamini-Hochberg multiple testing correction was used to estimate the FDR. BEST4/OTOP2 cell marker overlap. The intersection of the top 200 markers for BEST4/OTOP2 cells-identified from 10× single-cell data, SmartSeq2 data, quantitative proteomics assays and previous datasets 15,21 -was visualized using the R package circos. Trajectory and pseudotime analysis. Cell-differentiation trajectories were reconstructed using the R package monocle (version 2.8.0) 65 . Non-epithelial-cell clusters were filtered out and dimensionality reduction was performed with the DDRTree algorithm, using all highly variable genes as inputs and the following residual model formula: ~donor + number of UMIs + percentage of mitochondrial gene expression + G1 score +G2M score. Cell trajectory was then reconstructed using the orderCells function and the starting state was denoted as the branch encompassing the previously identified stem cells at the most distal end.
To identify putative lineage regulators, we first identified genes that change between secretory and absorptive branches using branched-expression-analysis modelling (negative binomial likelihood ratio test), modelling pseudotime as a covariate. Then, we identified genes that are induced before the trajectory bifurcation point by performing a differential expression test between the cells in the earliest trajectory state, as identified by Monocle, and later prebranch state cells. All significantly upregulated (less than 1% FDR, greater than 0 fold change (expressed in log 2 )) genes were then intersected with all previously identified genes that showed significant pseudotime-varying, branch-specific expression. This subset identified genes with branch-specific expression that are also induced before lineage divergence. In all of the above statistical tests, patient/sample batches, cell-cycle scores, cell-size factors and percentage of mitochondrial gene expression were modelled as covariates. Analysis of tissue-specific expression of GWAS loci. We used the SNPsea algorithm 24 to test for significant enrichment of tissue-specific expression in ulcerative-colitisassociated GWAS loci genes. From the GWAS catalogue 66 , we downloaded the ulcerative-colitis-associated loci from refs. 25, 26 , which report the largest number of ulcerative-colitis-associated loci to date. We used data from the 1000 Genomes Project 67 to sample matched control single-nucleotide polymorphisms (SNPs) and to link SNPs to genes. We first used Gene Atlas gene-expression data (accession number GSE1133) to recapitulate the previous association of T-cell-specific gene-expression enrichment 68 in IBD-associated loci. For single-cell RNA-seq data, we created a 'pseudobulk' dataset for each previously identified cell cluster in health and ulcerative colitis separately by summing all UMI counts for each gene in each cluster. We then normalized the data by computing size factors (R package DESeq2, version 1.20.0) to account for differences in cell-cluster sizes. In all cases, SNPsea was run with the following parameters: -slop 10e3, -threads 8, -null-snpsets 1000, -min-observations 100, -max-iterations 1e7, -score single. Obtained P values were further subjected to Benjamini-Hochberg multiple testing correction. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
Raw and processed sequencing data files are available under the GEO accession number GSE116222. The source code for analyses has been deposited at https:// github.com/agneantanaviciute/colonicepithelium. Proteomics data have been deposited at the ProteomeXchange Consortium (http://www.proteomexchange. org) via the PRIDE 69 partner repository with the dataset identifiers PXD011655 and 10.6019/PXD011655. Fig. 1 | Identification and validation of epithelial-cell subpopulations. This figure is related to Fig. 1. a, i-iv Monocle analysis (n = 3). Dimension (Dim) 1 and 2 are on the x-and y-axis respectively. i, Branch-specific expression of selected SC markers, secretory-lineage-specific markers and putative novel lineage-specific transcriptional regulators (n = 3). j, Selected Gene Ontology terms that show significant enrichment among all marker genes for epithelial clusters. The number of markers identified for each cluster is indicated (x-axis). The size of each circle corresponds to the proportion of markers annotated to a given term, while the colour indicates the significance (FDR) (n = 3 biological replicates; hypergeometric test and FDR calculated; BenjaminiHochberg multiple testing correction).
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Raw sequencing data generated in this study are available on Gene Expression Omnibus, accession number GSE116222. The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium via the PRIDE 101 partner repository with the dataset identifiers PXD011655 and 10.6019/PXD011655
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Sample size
No formal sample size calculation was performed for patient samples which underwent single cell RNA sequencing in the first instance. 3 samples from healthy, non-inflamed UC and inflamed UC was chosen for single cell sequencing to allow for patient variability. For valdiation experiments of gene and protein targets a sample size was not calculated but biological and technical repeats were performed to allow quantification of statistical differences where nescessary with frequency reported for each individual experiment.
Data exclusions No data exclusion of patient data was performed.
Replication
All single cell experiments, immunohistochemistry stains, in-situ hybridisation stains and flow cytometry quantification experiments were performed on multiple occasions, most frequently >3, in order to ensure reliability and reproducibility of results. Exact quantification for each replicate is described in methods and figure legends.
Randomization No randomization was performed
Blinding
Interpretation of WFDC2 staining intensity from patient samples was performed by 3 individuals who were blinded as to patient severity score, which was then further quantified using imaging software, as per the description in the methods. In other areas of results blinding was not necessary.
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Full details of patient demographics including age,gender and disease severity are presented in supplementary table 1.
For validation experiments including FACS, proteomics, smart-seq2 and immunohistochemistry / smISH quantification patient samples were collected in a similar manner under the same ethical approvals with healthy controls undergoing routine colonoscopy and samples form patients with ulcerative colitis being from active or inactive inflammation but samples were stored in formalin for further processing as per methods section.
Recruitment
Recruitment was as described above. Measures to avoid bias included balancing of patient genders for single cell analysis and severity blinding in IHC quantification as previously described within the methodology of each experiment.
Flow Cytometry Plots
Confirm that:
The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of identical markers).
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Methodology Sample preparation
For flow cytometry quantification samples were processed identically to those methods described in methods section. Following this they were then washed with FACs buffer (50ml PBS with 2% Fetal Calf Serum and 0.25mM EDTA) and were then stained with appropriate antibodies for 30 minutes. Samples were then washed and processed directly as described without fixation. Prior to running samples compensations were calculated with an unstained cellular control, compensation beads (BD) and a stained DAPI control which had been placed on a heat block for 10 minutes prior to antibody addition. This process was performed both for the flow cytometry quantification experiments and sorting experiments.
Instrument
For sample collection without sorting (quantification of populations) FACS was performed on the Attune NxT. For sorting experiment to quantify gene expression in EpCAM+CD45-population (Supplementary figure 1b) sorting was performed on a Facs Aria IIIu. For sorting experiments to validate the BEST4/OTOP2 populations (smartseq2, proteomic, microfluidic RT-PCR) sorting was performed on a SonySH800 (Sony)
Software
As per instrument description samples run on the Attune NxT had data collected with Attune NxT Software v 2.7.0 and for sorting experiments it was collected on the FacsAria IIIu. In both instances FCS files were then exported for further quantitiative analysis using FlowJo (v.10) as described previously.
Cell population abundance For quantification and sorting experiments epithelial cells were identified by gating on FSC and SSC and then by excluding doublets. In the case of population quantification (supplementary Figure 1a) this was then used as the denominator for calcuating percentage positive of each of the defined populations (Epcam+ / CD45+ /CD90+ and viability = DAPI-) as described in figure legends, with percentages and axis described. Population abundance was calculated using histogram plots of count vs appropriate channel as shown in figure. For sorting experiments the identification of epithelial cells in an identical manner with EpCAM+CD45-cells then sorted as shown in Figure Supplementary 1b . For flow sorting of bestrophin4+ cells an example of gating strategy is given in Extended Figure 2g which demonstrates the placement of a gate for the positive population with a FMO control. As described in methods for each sorting experiment an unstained, fluorescence minus on and secondary control sample was used in order to place the EpCAM+BEST4+/-gates.
Gating strategy
Gating strategies are described above, in figure legends and examples are given in relevant figures as mentioned in "Cell population abundance"
Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
